Company News_News_Hubei LingZe Pharmaceutical Technology Co.,Ltd.

Congratulations to the official launch of the new website of Hubei Lingze Pharmaceutical Technology Co., Ltd.

Hubei Lingze Pharmaceutical Technology Co., Ltd. is a limited liability company jointly established by Hubei Feilai Pharmaceutical Technology Co., Ltd. and Shaoxing Minsheng Pharmaceutical Co., Ltd. with a registered capital of 56.88 million yuan. Its business scope is the production and sales of chemical and pharmaceutical intermediate products. Registered in Makou Pharmaceutical and Chemical Industrial Park, Tian Town, Wuxue City, Hubei Province.

17 2021/05

Congratulations to the official launch of the new website of Hubei Lingze Pharmaceutical Technology Co., Ltd.

Guangdong Provincial Drug Administration launches unannounced inspections of medical device manufacturers in 2020

Recently, the Guangdong Provincial Food and Drug Administration organized the first batch of unannounced inspection work deployment meetings for medical device manufacturers in 2020,

08 2021/07

Guangdong Provincial Drug Administration launches unannounced inspections of medical device manufacturers in 2020

The Dawan District Center for Drug Evaluation and Inspection of the National Medical Products Administration took the lead in launching the on-site inspection of drug registration

In order to implement the work deployment of the National Medical Products Administration and perform its duties as soon as possible to carry out business work, from May 8 to 13,

08 2021/07

The Dawan District Center for Drug Evaluation and Inspection of the National Medical Products Administration took the lead in launching the on-site inspection of drug registration

The Center for the Greater Bay Area of Pharmaceuticals successfully held a series of special training sessions on technical guidelines for post-marketing drug changes

From May 18th to 19th, sponsored by the Center for Drug Evaluation and Inspection of the National Medical Products Administration of the Greater Bay Area (hereinafter referred to as the Greater

08 2021/07

The Center for the Greater Bay Area of Pharmaceuticals successfully held a series of special training sessions on technical guidelines for post-marketing drug changes

New crown virus vaccine manufacturer dispatched inspector advanced training class to start

In December 2018, the State Affairs Office of the Central Committee of the People's Republic of China issued the "Opinions on Reforming and Improving the Vaccine Management System" and made a top-level design for dispatching inspectors to vaccine manufacturers. In June 2019, the 11th meeting of the Standing Committee of the 13th National People's Congress deliberated and passed the "Vaccine Management Law", which required the dispatch of inspectors to vaccine manufacturers from the legal level.

08 2021/07

New crown virus vaccine manufacturer dispatched inspector advanced training class to start

The State Food and Drug Administration held a video and telephone conference to strengthen the quality supervision of medical devices for epidemic prevention and control

On July 7, the State Food and Drug Administration held a teleconference on strengthening the quality supervision of medical devices for epidemic prevention and control. The meeting summarized the previous stage of the epidemic prevention and control medical device quality and safety supervision work, analyzed the current supervision work situation, and re-emphasized, re-advanced, and re-implemented the further strengthening of the epidemic prevention and control medical device quality and safety supervision. Xu Jinghe, deputy director of the State Food and Drug Administration, attended the meeting and delivered a speech.

08 2021/07

The State Food and Drug Administration held a video and telephone conference to strengthen the quality supervision of medical devices for epidemic prevention and control

Hubei LingZe Pharmaceutical Technology Co.,Ltd.

About